Xlife Sciences AG
SIX:XLS
Xlife Sciences AG
SIX:XLS
Price:
20.3
CHF
-5.14%
Market Closed
Market Cap:
CHf117.1m
Relative Value
The Relative Value of one
XLS
stock under the Base Case scenario is
1.31
CHF.
Compared to the current market price of 20.3 CHF,
Xlife Sciences AG
is
Overvalued by 94%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XLS
Relative Value
Base Case
1.31
CHF
Overvaluation 94%
Multiples Across Competitors
XLS Competitors Multiples
Xlife Sciences AG Competitors
Xlife Sciences AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Xlife Sciences AG
SIX:XLS
|
117.7m CHF | 138.9 | 3.8 | -50.8 | -8.8 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 384.4 | 4 552.1 | 1 443.2 | 3 083.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
204.9B USD | 4.6 | 30.6 | 21.2 | 28.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
153.2B USD | 6.2 | 42.4 | 23.4 | 35.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
46.3T KRW | 8.4 | 29 | 16.9 | 22.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.4B CHF | 5.5 | 37.6 | 27.7 | 27.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280B CNY | 6.3 | 18.7 | 18.8 | 18.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
36.9B USD | 5.3 | 28.3 | 20.6 | 24.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
31.9B USD | 2 | 23.4 | 12.7 | 19.1 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.3B USD | 7.2 | 33.8 | 24.4 | 27.1 | |
| US |
|
Waters Corp
NYSE:WAT
|
22.8B USD | 7.4 | 35.2 | 22.7 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
